EUVIMEDEUVIMED entdecken
Crossref

Adjunctive GM-CSF therapy enhances host defense against systemic Candida auris infection in immunosuppressed miceAdjunctive GM-CSF therapy enhances host defense against systemicCandida aurisinfection in immunosuppressed mice

Eliciane Cevolani Mattos, Kaustav Das Gupta, Derek Quintanilla, Haley Hautau, Ashraf S. Ibrahim, Shakti Singh

Health Research Alliance · 17.02.2026

DOI: 10.25376/hra.31351306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Research Alliance, erschienen am 17.02.2026. Verfasst von Eliciane Cevolani Mattos und 5 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction:Candida aurisis an emerging, multidrug-resistant fungal pathogen associated with high mortality in immunocompromised individuals. Resistance to current antifungal drugs emphasizes the need for new therapeutic approaches. We investigated granulocyte-macrophage colony-stimulating factor (GM-CSF) as a standalone immunotherapy and in combination with a sub-therapeutic dose of micafungin in an immunosuppressed mouse model of systemicC. aurisinfection.

Methods

Immunosuppressed ICR CD-1 mice (4–6 weeks old) were infected withC. aurisand treated daily via intraperitoneal injection with PBS (placebo), murine GM-CSF (0.2 or 2 μg), micafungin, or both. Treatments began 24 h post-infection and continued through day 4 (GM-CSF) or day 7 (micafungin). Survival, tissue fungal burden, histopathology, and immune cell frequencies in spleen and kidneys were assessed. GM-CSF effects on neutrophil and macrophage antifungal functions were evaluated inex vivoassays.

Results

GM-CSF monotherapy significantly improved survival (30–32% vs. 0% in controls), extended median survival time, and reduced fungal burden in the kidney, heart, and brain. Although the combination therapy yielded the highest survival rate, it did not differ significantly from GM-CSF alone. Histopathological examination confirmed decreased fungal load and tissue damage in GM-CSF-treated mice. Additionally, GM-CSF augmented macrophage and neutrophil populations in spleen and kidney, enhanced fungal uptake and killing via reactive oxygen species and neutrophil extracellular traps.

Discussion

GM-CSF augments antifungal immunity and represents a promising adjunctive immunotherapy against MDRC. aurisinfection.

Schlagwörter

Candida aurisGM-CSFmicafunginadjunctive immunotherapyantifungal immunityimmunosuppressionneutrophilsmacrophagesneutrophil extracellular trapsreactive oxygen species

Zitieren

APA

Mattos, E. C., Gupta, K. D., Quintanilla, D., Hautau, H., Ibrahim, A. S., & Singh, S. (2026). Adjunctive GM-CSF therapy enhances host defense against systemic Candida auris infection in immunosuppressed miceAdjunctive GM-CSF therapy enhances host defense against systemicCandida aurisinfection in immunosuppressed mice. Health Research Alliance. https://doi.org/10.25376/hra.31351306

Vancouver

Mattos EC, Gupta KD, Quintanilla D, Hautau H, Ibrahim AS, Singh S. Adjunctive GM-CSF therapy enhances host defense against systemic Candida auris infection in immunosuppressed miceAdjunctive GM-CSF therapy enhances host defense against systemicCandida aurisinfection in immunosuppressed mice. Health Research Alliance. 2026. doi:10.25376/hra.31351306

BibTeX
@article{Mattos2026,
  author = {Mattos, Eliciane Cevolani and Gupta, Kaustav Das and Quintanilla, Derek and Hautau, Haley and Ibrahim, Ashraf S. and Singh, Shakti},
  title = {Adjunctive GM-CSF therapy enhances host defense against systemic Candida auris infection in immunosuppressed miceAdjunctive GM-CSF therapy enhances host defense against systemicCandida aurisinfection in immunosuppressed mice},
  journal = {Health Research Alliance},
  year = {2026},
  doi = {10.25376/hra.31351306}
}
Kostenlos starten →